Journal
CLINICAL INFECTIOUS DISEASES
Volume 47, Issue 9, Pages 1226-1230Publisher
OXFORD UNIV PRESS INC
DOI: 10.1086/592302
Keywords
-
Categories
Funding
- NIAAA NIH HHS [U10 AA013566, 2U10 AA 13566] Funding Source: Medline
- NIA NIH HHS [AG023024-01A1] Funding Source: Medline
Ask authors/readers for more resources
The US Food and Drug Administration has issued a warning that tipranavir may be associated with increased risk of intracranial hemorrhage. We studied 2 large cohorts to estimate the background rate of intracranial hemorrhage and compared it with rates reported among persons who had been exposed to tipranavir.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
